Ophthalmology and Therapy最新文献

筛选
英文 中文
A Novel Device for Vergence Exercises: Testing Automatic Dual Rotational Risley Prisms on Asymptomatic Adults and Patients with Convergence Insufficiency. 用于辐辏练习的新型设备:在无症状成人和辐辏障碍患者身上测试自动双旋转 Risley 棱镜。
IF 2.6 3区 医学
Ophthalmology and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-28 DOI: 10.1007/s40123-024-01055-1
Ya-Yu Chen, Yun-Shao Hu, Shuan-Yu Huang, Tzu-Hsun Tsai
{"title":"A Novel Device for Vergence Exercises: Testing Automatic Dual Rotational Risley Prisms on Asymptomatic Adults and Patients with Convergence Insufficiency.","authors":"Ya-Yu Chen, Yun-Shao Hu, Shuan-Yu Huang, Tzu-Hsun Tsai","doi":"10.1007/s40123-024-01055-1","DOIUrl":"10.1007/s40123-024-01055-1","url":null,"abstract":"<p><strong>Introduction: </strong>This study investigated the effects of automatic dual rotational Risley prisms (ADRRPs), a mobile phone application-operated device, on vergence abilities in young adults.</p><p><strong>Methods: </strong>Fifty-six participants aged 20-24 performed vergence exercises. The test group used prisms with power changes from 30Δ base-out to 10Δ base-in, while the control group used plano lenses for 10 min. Ophthalmic examinations included lateral heterophoria, near point of convergence (NPC), vergence facility (VF), negative fusional vergence (NFV), and positive fusional vergence (PFV), all measured before and after the vergence exercises. Pre- and post-test results were analyzed using a paired sample t test. Additionally, three cases with convergence insufficiency (CI) performed similar exercises for 12 weeks.</p><p><strong>Results: </strong>Participants were divided into the test group (n = 39; age 21.82 ± 1.10 years) and control group (n = 17; age 20.53 ± 0.51 years). In the test group, NPC improved from 6.11 ± 2.52 cm to 5.77 ± 2.30 cm (p = 0.023). VF increased from 13.75 ± 4.10 cpm to 16.50 ± 4.42 cpm (p = 0.007). PFV at 6 m and 0.4 m increased from 19.49 ± 6.77∆ to 22.19 ± 6.64∆ (p < 0.001) and 20.51 ± 7.05∆ to 22.69 ± 6.44∆ (p = 0.012), respectively. After 12 weeks, convergence insufficiency symptom survey scores for cases with CI decreased significantly, with NPC improving from 7.0 to 0 cm, 6.0 to 5.8 cm, and 6.0 to 4.7 cm. PFV increased from 10 to 25∆, 20 to 30∆, and 25 to 50∆.</p><p><strong>Conclusion: </strong>This preliminary study showed the effect of ADRRPs on improving vergence abilities. Further studies are needed to investigate the long-term sustainability and effects in a larger population of individuals with CI of this approach.</p>","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":" ","pages":"3189-3201"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Correlation Between Retinal Arteriolar Bifurcation Parameters and Coronary Atherosclerosis. 评估视网膜动脉分叉参数与冠状动脉粥样硬化之间的相关性
IF 2.6 3区 医学
Ophthalmology and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-14 DOI: 10.1007/s40123-024-01038-2
Guangzheng Dai, Geng Wang, Sile Yu, Weinan Fu, Shenming Hu, Yue Huang, Xinze Luan, Xue Cao, Xiaoting Wang, Hairu Yan, Xinying Liu, Xingru He
{"title":"Assessing the Correlation Between Retinal Arteriolar Bifurcation Parameters and Coronary Atherosclerosis.","authors":"Guangzheng Dai, Geng Wang, Sile Yu, Weinan Fu, Shenming Hu, Yue Huang, Xinze Luan, Xue Cao, Xiaoting Wang, Hairu Yan, Xinying Liu, Xingru He","doi":"10.1007/s40123-024-01038-2","DOIUrl":"10.1007/s40123-024-01038-2","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to examine the relationship between the morphological parameters of retinal arteriolar bifurcations and coronary artery disease (CAD).</p><p><strong>Methods: </strong>In this cross-sectional observational study, fundus photography was conducted on 444 participants to capture retinal arteriolar bifurcations. A total of 731 fundus photographs yielded 9625 measurable bifurcations. Analyzed bifurcation parameters included the diameters of the parent vessel (d<sub>0</sub>), the larger branch (d<sub>1</sub>), and the smaller branch (d<sub>2</sub>), as well as the angles (θ<sub>1</sub>) and (θ<sub>2</sub>) representing the orientation of each branch in relation to the parent vessel, respectively. Additionally, theoretical optimal angles ( <math><msubsup><mi>θ</mi> <mrow><mn>1</mn></mrow> <mo>'</mo></msubsup> </math> ) and ( <math><msubsup><mi>θ</mi> <mrow><mn>2</mn></mrow> <mo>'</mo></msubsup> </math> ), calculated from the measured parameters, provided a benchmark for ideal bifurcation geometry. The study assessed the variation in these parameters across different levels of coronary atherosclerosis severity.</p><p><strong>Results: </strong>After adjusting for anatomical characteristics including the asymmetry ratio, area ratio, and distance to the optic disc, we observed that patients with severe coronary artery stenosis had significant deviations from the theoretical optimal bifurcation angles, with a decrease in ( <math><msubsup><mi>θ</mi> <mrow><mn>1</mn></mrow> <mo>'</mo></msubsup> </math> ) and an increase in ( <math><msubsup><mi>θ</mi> <mrow><mn>2</mn></mrow> <mo>'</mo></msubsup> </math> ) compared to those with moderate stenosis.</p><p><strong>Conclusion: </strong>The findings suggest a clear alteration in retinal arteriolar bifurcation morphology among patients with severe CAD, which could potentially serve as an indicator of disease severity.</p>","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":" ","pages":"3079-3093"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564501/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is Occluding Our Understanding of Retinal Vein Occlusion? 是什么阻碍了我们对视网膜静脉闭塞的理解?
IF 2.6 3区 医学
Ophthalmology and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-10 DOI: 10.1007/s40123-024-01042-6
Christiana Dinah, Andrew Chang, Junyeop Lee, William W Li, Rishi Singh, Lihteh Wu, David Wong, Insaf Saffar
{"title":"What is Occluding Our Understanding of Retinal Vein Occlusion?","authors":"Christiana Dinah, Andrew Chang, Junyeop Lee, William W Li, Rishi Singh, Lihteh Wu, David Wong, Insaf Saffar","doi":"10.1007/s40123-024-01042-6","DOIUrl":"10.1007/s40123-024-01042-6","url":null,"abstract":"","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":" ","pages":"3025-3034"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Micropulse Laser versus Eplerenone for Chronic Central Serous Chorioretinopathy: A 12-Month Comparison. 微脉冲激光与依普利酮治疗慢性中心性浆液性脉络膜视网膜病变:为期 12 个月的比较。
IF 2.6 3区 医学
Ophthalmology and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-26 DOI: 10.1007/s40123-024-01059-x
Pasquale Viggiano, Giacomo Boscia, Enrico Borrelli, Federica Evangelista, Ermete Giancipoli, Rodolfo Mastropasqua, Alberto Quarta, Maria Oliva Grassi, Raffaella Aloia, Giovanni Alessio, Lisa Toto, Francesco Boscia
{"title":"Micropulse Laser versus Eplerenone for Chronic Central Serous Chorioretinopathy: A 12-Month Comparison.","authors":"Pasquale Viggiano, Giacomo Boscia, Enrico Borrelli, Federica Evangelista, Ermete Giancipoli, Rodolfo Mastropasqua, Alberto Quarta, Maria Oliva Grassi, Raffaella Aloia, Giovanni Alessio, Lisa Toto, Francesco Boscia","doi":"10.1007/s40123-024-01059-x","DOIUrl":"10.1007/s40123-024-01059-x","url":null,"abstract":"<p><strong>Introduction: </strong>To compare the long-term efficacy of navigated subthreshold micropulse laser (NSML) and continuous oral eplerenone (EPL) in chronic central serous chorioretinopathy (cCSC).</p><p><strong>Methods: </strong>This retrospective observational study included 44 eyes with cCSC (EPL: n = 26; NSML: n = 18). Best-corrected visual acuity (BCVA), central macular thickness (CMT), subretinal fluid (SRF) height, and subfoveal choroidal thickness (SFCT) were evaluated over 12 months.</p><p><strong>Results: </strong>Both groups showed significant improvements in BCVA and CMT (p < 0.05). Complete SRF resolution was achieved in both groups by 12 months, with NSML showing faster resolution (2.77 ± 1.43 vs. 6.34 ± 2.17 months, p < 0.001). The EPL group demonstrated significant SFCT reduction at 6 and 12 months (p = 0.001), while the NSML group showed no significant SFCT changes (p > 0.05).</p><p><strong>Conclusions: </strong>Both NSML and EPL improved retinal morphology and visual function in patients with cCSC. NSML achieved faster SRF resolution, while EPL resulted in more significant choroidal thickness reduction. These findings suggest distinct mechanisms of action: NSML primarily affects the retinal pigment epithelium, while EPL modulates choroidal vasculature. Treatment choice may depend on individual patient characteristics and treatment goals.</p>","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":" ","pages":"3175-3188"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564717/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraretinal Microvascular Abnormalities in Eyes with Advanced Stages of Nonproliferative Diabetic Retinopathy: Comparison Between UWF-FFA, CFP, and OCTA-The RICHARD Study. 非增生性糖尿病视网膜病变晚期患者视网膜内微血管异常:UWF-FFA、CFP 和 OCTA 的比较--RICHARD 研究。
IF 2.6 3区 医学
Ophthalmology and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-26 DOI: 10.1007/s40123-024-01054-2
Ana R Santos, Marta Lopes, Torcato Santos, Débora Reste-Ferreira, Inês P Marques, Taffeta C N Yamaguchi, Telmo Miranda, Luís Mendes, António C V Martinho, Liz Pearce, José Cunha-Vaz
{"title":"Intraretinal Microvascular Abnormalities in Eyes with Advanced Stages of Nonproliferative Diabetic Retinopathy: Comparison Between UWF-FFA, CFP, and OCTA-The RICHARD Study.","authors":"Ana R Santos, Marta Lopes, Torcato Santos, Débora Reste-Ferreira, Inês P Marques, Taffeta C N Yamaguchi, Telmo Miranda, Luís Mendes, António C V Martinho, Liz Pearce, José Cunha-Vaz","doi":"10.1007/s40123-024-01054-2","DOIUrl":"10.1007/s40123-024-01054-2","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to evaluate intraretinal microvascular abnormalities (IRMA) in eyes with advanced nonproliferative diabetic retinopathy (NPDR) using multimodal approach in co-located areas focusing on central retina (up to 50°) and to look at possible correlations between IRMA and other structural changes, like ischemia and presence of microaneurysms.</p><p><strong>Methods: </strong>The RICHARD study (NCT05112445) included 60 eyes from 60 patients with type 2 diabetes with moderate-severe NPDR, diabetic retinopathy severity levels 43, 47, and 53 (DRSS). IRMA were defined as capillary tortuosity covering a minimum circular area of 300 µm (calculated to correspond to the Early Treatment Diabetic Retinopathy Study standard photo 8A) and were identified using multimodal imaging with distinct fields of view (FoV): color fundus photography (CFP) using a Topcon TRC-50DX camera (Topcon Medical Systems, Japan), Optos California ultra wide field fundus fluorescein angiography (UWF-FFA) (Optos plc, UK), and swept-source optical coherence tomography angiography (SS-OCTA) (PLEX® Elite 9000, ZEISS, USA). Different areas of the retina were examined: central macula (up to 20°) and posterior pole (between 20° and 50°).</p><p><strong>Results: </strong>Multimodal imaging was used to identify IRMA in co-located areas (FoV < 50°) including UWF-FFA, CFP, and SS-OCTA. In eyes with DRSS levels 47 and 53, IRMA were identified in both areas of the retina, while in eyes with DRSS level 43, IRMA were detected only outside of the central macula (FoV > 20°). Our results show that when evaluating the presence of IRMA (FoV < 50°), UWF-FFA detected 203 IRMA, SS-OCTA detected 133 IRMA, and CFP detected 104 IRMA. Our results also show that the presence of IRMA was positively associated with presence of microaneurysms.</p><p><strong>Conclusions: </strong>Identification of IRMA in eyes with advanced NPDR is better achieved by UWF-FFA than CFP and SS-OCTA. A statistically significant correlation was found between the presence of IRMA and the increase in number of microaneurysms.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov, identifier NCT05112445.</p>","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":" ","pages":"3161-3173"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geometry of Modern Presbyopia-Correcting Intraocular Lenses and Changes in Haptic-Capsular Bag Behavior According to Compression and Different Well Diameters: A Bench Study Using Computed Tomography. 现代老花眼矫正眼内透镜的几何形状以及压迫和不同井径导致的触囊行为变化:使用计算机断层扫描的台架研究。
IF 2.6 3区 医学
Ophthalmology and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-09 DOI: 10.1007/s40123-024-01046-2
Andreas F Borkenstein, Eva-Maria Borkenstein
{"title":"Geometry of Modern Presbyopia-Correcting Intraocular Lenses and Changes in Haptic-Capsular Bag Behavior According to Compression and Different Well Diameters: A Bench Study Using Computed Tomography.","authors":"Andreas F Borkenstein, Eva-Maria Borkenstein","doi":"10.1007/s40123-024-01046-2","DOIUrl":"10.1007/s40123-024-01046-2","url":null,"abstract":"<p><strong>Introduction: </strong>The geometry of an intraocular lens (IOL), the design of the haptics, and the optic-haptic junction play a role in initial and long-term visual outcome after cataract surgery. Knowledge of the behavior of an implant in the capsular bag and under compression is of major importance. Our laboratory experiment analyzed in-depth the geometry of acrylic, single-piece, premium, presbyopia-correcting intraocular lenses and changes in haptic-capsular bag relationships according to capsular bag size using a range of compression well diameters.</p><p><strong>Methods: </strong>One hydrophilic (RayOne Trifocal<sup>®</sup> RAO603F) and three hydrophobic intraocular lenses (AcrySof IQ PanOptix<sup>®</sup>, Synergy DFR00V™, and AT ELANA 841P<sup>®</sup>) were scanned with computed tomography (CT) in a dry, uncompressed state for quantitative analyses of haptic and optic-haptic junction (OHJ) dimensions and qualitative assessment of geometry. In the second part of the experiment, CT was performed after sample placement into a series of compression wells (9.0, 10.0, 11.0, 11.5 mm) for analyses of length of contact (LoC) between the haptics and the wells. Axial alignment and haptic-capsular bag relationships were assessed.</p><p><strong>Results: </strong>The qualitative and quantitative evaluations highlighted differences in haptic and OHJ geometry and dimensions across the samples. The mid-zone of the optic was thickest in the hydrophilic sample (RayOne Trifocal<sup>®</sup> RAO603F) with a maximum of 0.880 mm compared to the thinnest hydrophobic sample (AT ELANA 841P<sup>®</sup>) with 0.564 mm. The AT ELANA 841P<sup>®</sup> showed the largest OHJ surface area (3.86 mm<sup>2</sup>) and OHJ volume (0.60 mm<sup>3</sup>) of the hydrophobic samples. The TECNIS Synergy DFR00V™ showed the thickest OHJ (0.51 mm), while the AcrySof IQ PanOptix<sup>®</sup> showed the thinnest OHJ (0.21 mm). The LoC values decreased with increasing well size for all tested samples. The AT ELANA 841P<sup>®</sup> showed the largest LoC and largest contact zones of hydrophobic samples in all wells.</p><p><strong>Conclusion: </strong>The laboratory experiments highlight differences in the haptics, the OHJ geometric characteristics, and behavior of samples in different well diameters. The results support the idea that specific IOL designs may have advantages or disadvantages depending on anatomical dimensions. We cannot make any classification or rating (good versus bad) for clinical practice on the basis these experimental results, as many other factors play a role. However, knowledge of IOL geometry seems important to select the best option in each individual case.</p>","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":" ","pages":"3059-3077"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142392238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema. 阿弗利百普与地塞米松治疗对糖尿病黄斑水肿患者视网膜外膜形成的影响
IF 2.6 3区 医学
Ophthalmology and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-25 DOI: 10.1007/s40123-024-01057-z
Hsin-Ho Chang, Sheng-Chu Chi, Shih-Jen Chen, Yu-Bai Chou, Tai-Chi Lin
{"title":"Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema.","authors":"Hsin-Ho Chang, Sheng-Chu Chi, Shih-Jen Chen, Yu-Bai Chou, Tai-Chi Lin","doi":"10.1007/s40123-024-01057-z","DOIUrl":"10.1007/s40123-024-01057-z","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to investigate the impact of aflibercept and dexamethasone (DEX) on the formation of epiretinal membrane (ERM) and their treatment outcomes in eyes with diabetic macular edema (DME).</p><p><strong>Methods: </strong>In this retrospective cohort study, medical records of 124 eyes from 429 patients diagnosed with DME were reviewed between June 2017 and June 2019. Patients were categorized into two groups: the aflibercept group (67 eyes) and the DEX group (57 eyes). The primary endpoint was the secondary ERM incidence following intravitreal treatments and its correlation across different medications. Secondary endpoints included longitudinal changes in best-corrected visual acuity (BCVA) and central macular thickness (CMT).</p><p><strong>Results: </strong>Over a 24-month follow-up, eyes treated with DEX had approximately a fourfold higher incidence of ERM development compared to aflibercept [hazard ratio (HR) = 3.97, p = 0.02]. These eyes also showed worse BCVA (p = 0.059) and increased CMT (p = 0.004), despite requiring fewer total injections (p = 0.000) in the survival analysis model. The cumulative probability of ERM formation was 13.7%. Additionally, DME eyes exhibited poor functional and anatomical outcomes after developing ERM, while age, A1c level, DR severity, initial BCVA and CMT, lens status, and previous laser treatment were not associated with an elevated incidence of ERM formation.</p><p><strong>Conclusion: </strong>Intravitreal DEX implantation in DME eyes resulted in a higher incidence of secondary ERM formation compared to aflibercept over a 2-year period. The therapeutic efficacy for DME was diminished following ERM development, leading to worse anatomical outcomes. New therapeutic approaches should be explored to prevent ERM formation while maintaining both anatomical and functional outcomes in DME treatment.</p>","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":" ","pages":"3149-3159"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564617/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Evaluation of Violet Light Filtration and High-Resolution Lathing on a Diffractive Extended Depth of Focus IOL. 衍射型延展焦深人工晶体的紫光过滤和高分辨率缝合临床评估
IF 2.6 3区 医学
Ophthalmology and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-25 DOI: 10.1007/s40123-024-01056-0
Daniel H Chang, Andrew A Kao, Laura K Huggins, Jacqueline N Albert, Jacqueline N Whinery, Brittany M Camirand
{"title":"Clinical Evaluation of Violet Light Filtration and High-Resolution Lathing on a Diffractive Extended Depth of Focus IOL.","authors":"Daniel H Chang, Andrew A Kao, Laura K Huggins, Jacqueline N Albert, Jacqueline N Whinery, Brittany M Camirand","doi":"10.1007/s40123-024-01056-0","DOIUrl":"10.1007/s40123-024-01056-0","url":null,"abstract":"<p><strong>Introduction: </strong>This study is a prospective, randomized, subject/evaluator-masked clinical trial in a single-center clinical setting. The purpose of the study is to compare the clinical performance of Tecnis Symfony Optiblue IOL (models ZXR00V and ZXW150) with violet light filter (VLF) and manufacturing improvements versus Tecnis Symfony IOL (models ZXR00 and ZXT150) with ultraviolet light filter (UVF) in patients undergoing cataract surgery.</p><p><strong>Methods: </strong>Patients with cataracts aged ≥ 22 years were randomly assigned 1:1 to bilateral implantation with ZXR00V/ZXW150 (VLF group) or ZXR00/ZXT150 (UVF group). Key endpoints at 6 months postoperative included patient reported nighttime dysphotopsia symptoms, 25% low contrast visual acuity with glare, and patient satisfaction.</p><p><strong>Results: </strong>Sixty patients were implanted with ZXR00V/ZXW150 (30) or ZXR00/ZXT150 (30). At 6 months, the VLF group did not show a statistically significant differences in mean monocular photopic uncorrected distance visual acuity (UCDVA), best-corrected distance visual acuity (BCDVA), uncorrected near visual acuity (UCNVA) (40 cm), or distance-corrected near visual acuity (DCNVA) (40 cm) compared to the UVF group. At 1 month, patients in the VLF group reported significantly less difficulty due to halo (p = 0.016) and starburst (p = 0.028) symptoms. By the 6 months, dysphotopsia complaints were no longer significantly different between the groups. Although the VLF group trended toward better low contrast visual acuity and patient satisfaction, statistical significance was not reached.</p><p><strong>Conclusions: </strong>Managing the patients' expectations is key to achieving success. At the 1-month visit the patients who reported dysphotopsia complaints in the VLF group had significantly less difficulty with starbursts and halos as compared to the UVF group. By the 6-month visit, there was no significant difference between the two groups in the difficulty with starbursts and halos.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov identifier, NCT06567834.</p>","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":" ","pages":"3135-3147"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564627/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Preservative-Free Combination of Sodium Hyaluronate and Trehalose Improves Dry Eye Signs and Symptoms and Increases Patient Satisfaction in Real-Life Settings: The TEARS Study. 不含防腐剂的透明质酸钠和曲哈洛糖复方制剂可改善干眼症症状,提高患者在实际生活中的满意度:TEARS研究。
IF 2.6 3区 医学
Ophthalmology and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-21 DOI: 10.1007/s40123-024-01044-4
Antonio J Mateo-Orobia, Sarah Farrant, Eduardo Del-Prado-Sanz, Alejandro Blasco-Martínez, Miriam Idoipe-Corta, Noelia Lafuente-Ojeda, Luis E Pablo-Júlvez
{"title":"A Preservative-Free Combination of Sodium Hyaluronate and Trehalose Improves Dry Eye Signs and Symptoms and Increases Patient Satisfaction in Real-Life Settings: The TEARS Study.","authors":"Antonio J Mateo-Orobia, Sarah Farrant, Eduardo Del-Prado-Sanz, Alejandro Blasco-Martínez, Miriam Idoipe-Corta, Noelia Lafuente-Ojeda, Luis E Pablo-Júlvez","doi":"10.1007/s40123-024-01044-4","DOIUrl":"10.1007/s40123-024-01044-4","url":null,"abstract":"<p><strong>Introduction: </strong>Dry eye disease (DED) is a frequently observed condition characterized by ocular discomfort and visual disturbance. It is highly prevalent and impairs patients' quality of life (QoL). This study assessed the benefit of a preservative-free bioprotectant eye drop formulation containing sodium hyaluronate and trehalose (SH-trehalose) with regards to DED, as well as patient satisfaction, through a large-scale real-life survey.</p><p><strong>Methods: </strong>In a multi-center, international, prospective observational study, subjects with DED received SH-trehalose for 84 days. Ocular Surface Disease Index (OSDI), Dry Eye Questionnaire-5 items (DEQ-5), and patient satisfaction were assessed at baseline, day 28, and day 84, and clinical evaluations included ocular surface staining, Schirmer test, tear film break-up time (TBUT), and conjunctival hyperemia at baseline and day 84.</p><p><strong>Results: </strong>A total of 312 patients were evaluated, of whom 82.4% were women. The mean age was 57.9 ± 15.2 years. The mean OSDI score at baseline was 41.7 ± 20.6. After 84 days, the mean OSDI score was 27.3 ± 19.8 (p < 0.001). The percentage of patients with a severe OSDI score decreased from 60.3 to 34.5%. The DEQ-5 score significantly (p < 0.001) improved after 28 and 84 days, as did patient satisfaction. Ocular surface staining, Schirmer test, TBUT, and conjunctival hyperemia scores improved significantly (all p < 0.001) for both eyes with SH-trehalose between baseline and day 84. Tolerance of SH-trehalose was good.</p><p><strong>Conclusions: </strong>SH-trehalose significantly improved the clinical signs and symptoms of DED after 84 days. Moreover, it significantly increased patient satisfaction and was well tolerated.</p><p><strong>Trial registration: </strong>NCT04803240.</p>","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":" ","pages":"3123-3134"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Response to: Letter to the Editor regarding "Efficacy of Multifocal Soft Contact Lenses in Reducing Myopia Progression Among Taiwanese Schoolchildren: A Randomized Paired-Eye Clinical Trial". 回应:致编辑的信,内容涉及 "多焦点软性隐形眼镜在降低台湾学童近视度数加深方面的功效:随机配对眼临床试验 "的编辑来信。
IF 2.6 3区 医学
Ophthalmology and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-21 DOI: 10.1007/s40123-024-01047-1
Yao-Lin Liu, Tzu-Hsun Tsai
{"title":"A Response to: Letter to the Editor regarding \"Efficacy of Multifocal Soft Contact Lenses in Reducing Myopia Progression Among Taiwanese Schoolchildren: A Randomized Paired-Eye Clinical Trial\".","authors":"Yao-Lin Liu, Tzu-Hsun Tsai","doi":"10.1007/s40123-024-01047-1","DOIUrl":"10.1007/s40123-024-01047-1","url":null,"abstract":"","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":" ","pages":"3219-3220"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信